{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:20:13Z","timestamp":1784841613728,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s10072-021-05400-1","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T08:03:04Z","timestamp":1627632184000},"page":"1239-1248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Autoimmune encephalitis: the first observational study from Iran"],"prefix":"10.1007","volume":"43","author":[{"given":"Masoud","family":"Etemadifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4713-0545","authenticated-orcid":false,"given":"Ali","family":"Aghababaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosein","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa K.","family":"Kargaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehri","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"issue":"4","key":"5400_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, H\u00f6ftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Pr\u00fcss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rost\u00e1sy K, Saiz A, Venkatesan A, Vincent A, Wandinger K-P, Waters P, Dalmau J (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15(4):391\u2013404. https:\/\/doi.org\/10.1016\/s1474-4422(15)00401-9","journal-title":"Lancet Neurol"},{"issue":"1","key":"5400_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/ana.25131","volume":"83","author":"D Dubey","year":"2018","unstructured":"Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP (2018) Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol 83(1):166\u2013177. https:\/\/doi.org\/10.1002\/ana.25131","journal-title":"Ann Neurol"},{"key":"5400_CR3","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.3389\/fimmu.2019.02611","volume":"10","author":"Y Gu","year":"2019","unstructured":"Gu Y, Zhong M, He L, Li W, Huang Y, Liu J, Chen Y, Xiao Z (2019) Epidemiology of antibody-positive autoimmune encephalitis in Southwest China: a multicenter study. Front Immunol 10:2611. https:\/\/doi.org\/10.3389\/fimmu.2019.02611","journal-title":"Front Immunol"},{"issue":"12","key":"5400_CR4","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1111\/epi.13929","volume":"58","author":"X Liu","year":"2017","unstructured":"Liu X, Yan B, Wang R, Li C, Chen C, Zhou D, Hong Z (2017) Seizure outcomes in patients with anti-NMDAR encephalitis: a follow-up study. Epilepsia 58(12):2104\u20132111. https:\/\/doi.org\/10.1111\/epi.13929","journal-title":"Epilepsia"},{"issue":"10","key":"5400_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1793","volume":"10","author":"P Ghimire","year":"2020","unstructured":"Ghimire P, Khanal UP, Gajurel BP, Karn R, Rajbhandari R, Paudel S, Gautam N, Ojha R (2020) Anti-LGI1, anti-GABABR, and Anti-CASPR2 encephalitides in Asia: a systematic review. Brain Behav 10(10):e01793. https:\/\/doi.org\/10.1002\/brb3.1793","journal-title":"Brain Behav"},{"key":"5400_CR6","unstructured":"Asian Countries by population (2020) https:\/\/www.worldometers.info\/population\/countries-in-asia-by-population\/. Accessed 22 Dec 2020"},{"key":"5400_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/ijpvm.IJPVM_417_18","volume":"10","author":"A Hakamifard","year":"2019","unstructured":"Hakamifard A, Naghibi SN, HashemiFesharaki SS (2019) Anti-NMDA receptor encephalitis presenting with status epilepticus: brucellosis as a possible triggering factor: a case report. Int J Prev Med 10:119. https:\/\/doi.org\/10.4103\/ijpvm.IJPVM_417_18","journal-title":"Int J Prev Med"},{"key":"5400_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.parkreldis.2019.07.023","volume":"66","author":"AR Tavasoli","year":"2019","unstructured":"Tavasoli AR, Shahidi G, Parvaresh M, Fasano A, Ashrafi MR, Hosseinpour S, Lang AE, Rohani M (2019) Deep brain stimulation in status dystonicus caused by anti-NMDA receptor encephalitis. Parkinsonism Relat Disord 66:255\u2013257. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.07.023","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"5400_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, Honnorat J, Smitt PS, Vedeler C, Verschuuren JJ, Vincent A, Voltz R (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75(8):1135\u20131140. https:\/\/doi.org\/10.1136\/jnnp.2003.034447","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"5400_CR10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/epi.13670","volume":"58","author":"RS Fisher","year":"2017","unstructured":"Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, Lagae L, Moshe SL, Peltola J, Roulet Perez E, Scheffer IE, Zuberi SM (2017) Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 58(4):522\u2013530. https:\/\/doi.org\/10.1111\/epi.13670","journal-title":"Epilepsia"},{"issue":"10","key":"5400_CR11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein DH (2015) A definition and classification of status epilepticus\u2013report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 56(10):1515\u20131523. https:\/\/doi.org\/10.1111\/epi.13121","journal-title":"Epilepsia"},{"issue":"4","key":"5400_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1017\/cjn.2016.13","volume":"43","author":"MM Gagnon","year":"2016","unstructured":"Gagnon MM, Savard M (2016) Limbic encephalitis associated with GAD65 antibodies: brief review of the relevant literature. Can J Neurol Sci 43(4):486\u2013493. https:\/\/doi.org\/10.1017\/cjn.2016.13","journal-title":"Can J Neurol Sci"},{"issue":"11","key":"5400_CR13","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/s1474-4422(19)30244-3","volume":"18","author":"J Dalmau","year":"2019","unstructured":"Dalmau J, Armangu\u00e9 T, Planagum\u00e0 J, Radosevic M, Mannara F, Leypoldt F, Geis C, Lancaster E, Titulaer MJ, Rosenfeld MR, Graus F (2019) An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol 18(11):1045\u20131057. https:\/\/doi.org\/10.1016\/s1474-4422(19)30244-3","journal-title":"Lancet Neurol"},{"key":"5400_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jocn.2018.03.026","volume":"52","author":"S Bacchi","year":"2018","unstructured":"Bacchi S, Franke K, Wewegama D, Needham E, Patel S, Menon D (2018) Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: a systematic review. J Clin Neurosci 52:54\u201359. https:\/\/doi.org\/10.1016\/j.jocn.2018.03.026","journal-title":"J Clin Neurosci"},{"issue":"1","key":"5400_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, Friedman D, Skeen MB, Grisold W, Kimura A, Ohta K, Iizuka T, Guzman M, Graus F, Moss SJ, Balice-Gordon R, Dalmau J (2010) Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9(1):67\u201376. https:\/\/doi.org\/10.1016\/s1474-4422(09)70324-2","journal-title":"Lancet Neurol"},{"issue":"9","key":"5400_CR16","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","volume":"76","author":"A Boronat","year":"2011","unstructured":"Boronat A, Sabater L, Saiz A, Dalmau J, Graus F (2011) GABAB receptor antibodies in limbic encephalitis and anti-GAD\u2013associated neurologic disorders. Neurology 76(9):795\u2013800","journal-title":"Neurology"},{"issue":"17","key":"5400_CR17","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","volume":"81","author":"R H\u00f6ftberger","year":"2013","unstructured":"H\u00f6ftberger R, Titulaer MJ, Sabater L, Dome B, R\u00f3zs\u00e1s A, Hegedus B, Hoda MA, Laszlo V, Ankersmit HJ, Harms L, Boyero S, de Felipe A, Saiz A, Dalmau J, Graus F (2013) Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 81(17):1500\u20131506. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a9585f","journal-title":"Neurology"},{"issue":"1","key":"5400_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00415-018-9132-0","volume":"266","author":"A Maureille","year":"2019","unstructured":"Maureille A, Fenouil T, Joubert B, Picard G, Rogemond V, Pinto AL, Thomas L, Ducray F, Quadrio I, Psimaras D, Berzero G, Antoine JC, Desestret V, Honnorat J (2019) Isolated seizures are a common early feature of paraneoplastic anti-GABAB receptor encephalitis. J Neurol 266(1):195\u2013206. https:\/\/doi.org\/10.1007\/s00415-018-9132-0","journal-title":"J Neurol"},{"key":"5400_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.seizure.2015.04.005","volume":"29","author":"R Wang","year":"2015","unstructured":"Wang R, Guan HZ, Ren HT, Wang W, Hong Z, Zhou D (2015) CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis. Seizure 29:137\u2013142. https:\/\/doi.org\/10.1016\/j.seizure.2015.04.005","journal-title":"Seizure"},{"issue":"7","key":"5400_CR20","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.clinph.2017.04.015","volume":"128","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Liu G, Jiang MD, Li LP, Su YY (2017) Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China. Clin Neurophysiol 128(7):1227\u20131233. https:\/\/doi.org\/10.1016\/j.clinph.2017.04.015","journal-title":"Clin Neurophysiol"},{"issue":"13","key":"5400_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019601","volume":"99","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Deng C, Zhu L, Ling L (2020) Predisposing factors and prognosis of status epilepticus in patients with autoimmune encephalitis. Medicine (Baltimore) 99(13):e19601. https:\/\/doi.org\/10.1097\/MD.0000000000019601","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"5400_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12(2):157\u2013165. https:\/\/doi.org\/10.1016\/s1474-4422(12)70310-1","journal-title":"Lancet Neurol"},{"issue":"10","key":"5400_CR23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1212\/WNL.0b013e3182a35271","volume":"81","author":"OJ Jeffery","year":"2013","unstructured":"Jeffery OJ, Lennon VA, Pittock SJ, Gregory JK, Britton JW, McKeon A (2013) GABAB receptor autoantibody frequency in service serologic evaluation. Neurology 81(10):882\u2013887","journal-title":"Neurology"},{"issue":"4","key":"5400_CR24","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3988\/jcn.2016.12.4.502","volume":"12","author":"YY Wu","year":"2016","unstructured":"Wu YY, Feng Y, Huang Y, Zhang JW (2016) Anti-N-methyl-D-aspartate receptor encephalitis in a patient with systemic lupus erythematosus. J Clin Neurol 12(4):502\u2013504. https:\/\/doi.org\/10.3988\/jcn.2016.12.4.502","journal-title":"J Clin Neurol"},{"key":"5400_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00737-020-01088-y","author":"S Zhang","year":"2020","unstructured":"Zhang S, Yang Y, Long T, Li Z (2020) Systemic lupus erythematosus associated with recurrent anti-NMDA receptor encephalitis during pregnancy. Arch Womens Ment Health. https:\/\/doi.org\/10.1007\/s00737-020-01088-y","journal-title":"Arch Womens Ment Health"},{"issue":"2","key":"5400_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.autrev.2016.12.002","volume":"16","author":"SH Tay","year":"2017","unstructured":"Tay SH, Fairhurst AM, Mak A (2017) Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A\/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sjogren\u2019s syndrome: an updated meta-analysis. Autoimmun Rev 16(2):114\u2013122. https:\/\/doi.org\/10.1016\/j.autrev.2016.12.002","journal-title":"Autoimmun Rev"},{"issue":"8","key":"5400_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102592","volume":"19","author":"SJ Deijns","year":"2020","unstructured":"Deijns SJ, Broen JCA, Kruyt ND, Schubart CD, Andreoli L, Tincani A, Limper M (2020) The immunologic etiology of psychiatric manifestations in systemic lupus erythematosus: a narrative review on the role of the blood brain barrier, antibodies, cytokines and chemokines. Autoimmun Rev 19(8):102592. https:\/\/doi.org\/10.1016\/j.autrev.2020.102592","journal-title":"Autoimmun Rev"},{"issue":"3","key":"5400_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/14397595.2015.1083163","volume":"26","author":"E Ogawa","year":"2016","unstructured":"Ogawa E, Nagai T, Sakuma Y, Arinuma Y, Hirohata S (2016) Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus. Mod Rheumatol 26(3):377\u2013383. https:\/\/doi.org\/10.3109\/14397595.2015.1083163","journal-title":"Mod Rheumatol"},{"issue":"62","key":"5400_CR29","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1212\/01.wnl.0000113749.77217.01","volume":"5","author":"L Bataller","year":"2004","unstructured":"Bataller L, Wade DF, Graus F, Stacey HD, Rosenfeld MR (2004) Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer. Neurology 5(62):778\u2013782. https:\/\/doi.org\/10.1212\/01.wnl.0000113749.77217.01","journal-title":"Neurology"},{"issue":"1","key":"5400_CR30","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.24189","volume":"76","author":"L Dahm","year":"2014","unstructured":"Dahm L, Ott C, Steiner J, Stepniak B, Teegen B, Saschenbrecker S, Hammer C, Borowski K, Begemann M, Lemke S, Rentzsch K, Probst C, Martens H, Wienands J, Spalletta G, Weissenborn K, Stocker W, Ehrenreich H (2014) Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol 76(1):82\u201394. https:\/\/doi.org\/10.1002\/ana.24189","journal-title":"Ann Neurol"},{"key":"5400_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.clineuro.2018.02.043","volume":"168","author":"R Salazar","year":"2018","unstructured":"Salazar R (2018) Atypical presentation of probable Creutzfeldt-Jakob disease associated with anti-Zic4 antibody: Literature review of neuronal antibodies in Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 168:72\u201376. https:\/\/doi.org\/10.1016\/j.clineuro.2018.02.043","journal-title":"Clin Neurol Neurosurg"},{"issue":"06","key":"5400_CR32","doi-asserted-by":"publisher","first-page":"397","DOI":"10.26502\/acmcr.96550110","volume":"03","author":"N Charalampakis","year":"2019","unstructured":"Charalampakis N, Tsoukalas N, Kykalos S, Tolia M (2019) Isolated ZIC4 antibodies and autoimmune encephalitis in a microsatellite-instability-high metastatic uterine carcinosarcoma during immune checkpoint inhibitor treatment. Arch Clin Med Case Rep 03(06):397\u2013401. https:\/\/doi.org\/10.26502\/acmcr.96550110","journal-title":"Arch Clin Med Case Rep"},{"key":"5400_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577192","volume":"341","author":"F Bernardo","year":"2020","unstructured":"Bernardo F, Rebordao L, Rego A, Machado S, Passos J, Costa C, Cruz S, Pinto AN, Santos M (2020) Stiff person spectrum disorders: an illustrative case series of their phenotypic and antibody diversity. J Neuroimmunol 341:577192. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577192","journal-title":"J Neuroimmunol"},{"issue":"15 Supplement","key":"5400_CR34","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1212\/WNL.94.15_supplement.2233","volume":"94","author":"M Alani","year":"2020","unstructured":"Alani M, Rossi F, Hoffmann M, Benes-Cases L, Sharma U, Tsakadze N (2020) Zic4 antibody positive autoimmune encephalitis responding to rituximab after failing first line therapies: a case report (2233). Neurology 94(15 Supplement):2233","journal-title":"Neurology"},{"issue":"1","key":"5400_CR35","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41398-020-00967-3","volume":"10","author":"D Endres","year":"2020","unstructured":"Endres D, Meixensberger S, Dersch R, Feige B, Stich O, Venhoff N, Matysik M, Maier SJ, Michel M, Runge K, Nickel K, Urbach H, Domschke K, Pruss H, Tebartz van Elst L (2020) Cerebrospinal fluid, antineuronal autoantibody, EEG, and MRI findings from 992 patients with schizophreniform and affective psychosis. Transl Psychiatry 10(1):279. https:\/\/doi.org\/10.1038\/s41398-020-00967-3","journal-title":"Transl Psychiatry"},{"issue":"2","key":"5400_CR36","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.mcn.2004.01.004","volume":"26","author":"J Aruga","year":"2004","unstructured":"Aruga J (2004) The role of Zic genes in neural development. Mol Cell Neurosci 26(2):205\u2013221. https:\/\/doi.org\/10.1016\/j.mcn.2004.01.004","journal-title":"Mol Cell Neurosci"},{"key":"5400_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jns.2019.06.021","volume":"404","author":"R El-Abassi","year":"2019","unstructured":"El-Abassi R, Soliman MY, Villemarette-Pittman N, England JD (2019) SPS: understanding the complexity. J Neurol Sci 404:137\u2013149. https:\/\/doi.org\/10.1016\/j.jns.2019.06.021","journal-title":"J Neurol Sci"},{"issue":"5","key":"5400_CR38","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrneurol.2017.43","volume":"13","author":"A van Sonderen","year":"2017","unstructured":"van Sonderen A, Petit-Pedrol M, Dalmau J, Titulaer MJ (2017) The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol 13(5):290\u2013301. https:\/\/doi.org\/10.1038\/nrneurol.2017.43","journal-title":"Nat Rev Neurol"},{"issue":"14","key":"5400_CR39","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/WNL.0000000000003173","volume":"87","author":"ATR van Sonderen","year":"2016","unstructured":"van Sonderen ATR, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MA, van Coevorden-Hameete MH, Wirtz PW, Schreurs MW, SillevisSmitt PA, Titulaer MJ (2016) Anti-LGI1 encephalitis: clinical syndrome and long-term follow- up. Neurology 87(14):1449\u20131456","journal-title":"Neurology"},{"issue":"8","key":"5400_CR40","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/ene.13324","volume":"24","author":"M Celicanin","year":"2017","unstructured":"Celicanin M, Blaabjerg M, Maersk-Moller C, Beniczky S, Marner L, Thomsen C, Bach FW, Kondziella D, Andersen H, Somnier F, Illes Z, Pinborg LH (2017) Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies - a national cohort study. Eur J Neurol 24(8):999\u20131005. https:\/\/doi.org\/10.1111\/ene.13324","journal-title":"Eur J Neurol"},{"issue":"2","key":"5400_CR41","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.24858","volume":"81","author":"A van Sonderen","year":"2017","unstructured":"van Sonderen A, Roelen DL, Stoop JA, Verdijk RM, Haasnoot GW, Thijs RD, Wirtz PW, Schreurs MW, Claas FH, SillevisSmitt PA, Titulaer MJ (2017) Anti-LGI1 encephalitis is strongly associated with HLA-DR7 and HLA-DRB4. Ann Neurol 81(2):193\u2013198. https:\/\/doi.org\/10.1002\/ana.24858","journal-title":"Ann Neurol"},{"issue":"2","key":"5400_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.24860","volume":"81","author":"TJ Kim","year":"2017","unstructured":"Kim TJ, Lee ST, Moon J, Sunwoo JS, Byun JI, Lim JA, Shin YW, Jun JS, Lee HS, Lee WJ, Yang AR, Choi Y, Park KI, Jung KH, Jung KY, Kim M, Lee SK, Chu K (2017) Anti-LGI1 encephalitis is associated with unique HLA subtypes. Ann Neurol 81(2):183\u2013192. https:\/\/doi.org\/10.1002\/ana.24860","journal-title":"Ann Neurol"},{"key":"5400_CR43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jns.2018.04.009","volume":"390","author":"J Kaneko","year":"2018","unstructured":"Kaneko J, Kanazawa N, Tominaga N, Kaneko A, Suga H, Usui R, Ishima D, Kitamura E, Akutsu T, Yoshida K, Nishiyama K, Iizuka T (2018) Practical issues in measuring autoantibodies to neuronal cell-surface antigens in autoimmune neurological disorders: 190 cases. J Neurol Sci 390:26\u201332. https:\/\/doi.org\/10.1016\/j.jns.2018.04.009","journal-title":"J Neurol Sci"},{"issue":"D1","key":"5400_CR44","first-page":"D783","volume":"48","author":"FFMA Gonzalez-Galarza","year":"2020","unstructured":"Gonzalez-Galarza FFMA, Santos EJ, Jones J, Takeshita LY, Ortega-Rivera ND, Del Cid-Pavon GM, Ramsbottom K, Ghattaoraya GS, Alfirevic A, Middleton D, Jones AR (2020) Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools. Nucleic Acids Res 48(D1):D783\u2013D788","journal-title":"Nucleic Acids Res"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05400-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-021-05400-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05400-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T12:15:24Z","timestamp":1725538524000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-021-05400-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,30]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["5400"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05400-1","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,30]]},"assertion":[{"value":"13 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Isfahan University of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Patients signed informed consent regarding publishing their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}